Vetter N, Meder B
    
    
    Herz. 2025; .
  
  
    PMID: 40080176
    
    
          DOI: 10.1007/s00059-025-05296-z.
      
 
                                  
  
    Manzi L, Buongiorno F, Narciso V, Florimonte D, Forzano I, Castiello D
    
    
    Diagnostics (Basel). 2025; 15(5).
  
  
    PMID: 40075788
    
          PMC: 11899404.
    
          DOI: 10.3390/diagnostics15050540.
      
 
                                  
  
    Tao S, Yu L, Li J, Wu J, Xia X, Li Y
    
    
    Syst Rev. 2025; 14(1):59.
  
  
    PMID: 40069806
    
          PMC: 11895376.
    
          DOI: 10.1186/s13643-025-02802-6.
      
 
                                  
  
    Radmehr E, Yazdanpanah N, Rezaei N
    
    
    J Transl Med. 2025; 23(1):249.
  
  
    PMID: 40022088
    
          PMC: 11871836.
    
          DOI: 10.1186/s12967-025-06269-w.
      
 
                                  
  
    Leo I, Figliozzi S, Ielapi J, Sicilia F, Torella D, Dellegrottaglie S
    
    
    J Clin Med. 2025; 14(4).
  
  
    PMID: 40004642
    
          PMC: 11856486.
    
          DOI: 10.3390/jcm14041112.
      
 
                              
              
                              
                                      
  Mutations in Filamin C Associated with Both Alleles Do Not Affect the Functioning of Mice Cardiac Muscles.
  
    Ilchuk L, Kochegarova K, Baikova I, Safonova P, Bruter A, Kubekina M
    
    
    Int J Mol Sci. 2025; 26(4).
  
  
    PMID: 40003875
    
          PMC: 11855563.
    
          DOI: 10.3390/ijms26041409.
      
 
                                          
                                                          
  The contemporary role of genetics in cardiovascular medicine: from phenotypes to precision diagnoses.
  
    Urtis M, Tagliani M, Bondavalli D, Paganini C, Cavaliere C, Vilardo V
    
    
    Eur Heart J Suppl. 2025; 27(Suppl 1):i67-i72.
  
  
    PMID: 39980787
    
          PMC: 11836717.
    
          DOI: 10.1093/eurheartjsupp/suae107.
      
 
                                          
                                                          
  The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.
  
    Corrado D, Graziano F, Bauce B, Bueno Marinas M, Calore C, Celeghin R
    
    
    Eur Heart J Suppl. 2025; 27(Suppl 1):i73-i82.
  
  
    PMID: 39980775
    
          PMC: 11836707.
    
          DOI: 10.1093/eurheartjsupp/suae108.
      
 
                                          
                                                          
  Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology.
  
    Mizia-Stec K, Gimeno J, Charron P, Elliott P, Kaski J, Maggioni A
    
    
    Open Heart. 2025; 12(1).
  
  
    PMID: 39961701
    
          PMC: 11836841.
    
          DOI: 10.1136/openhrt-2024-002876.
      
 
                                          
                                                          
  An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models.
  
    Wang P, Ahmed M, Nguyen N, Menendez-Montes I, Hsu C, Farag A
    
    
    J Clin Invest. 2025; 135(4).
  
  
    PMID: 39959972
    
          PMC: 11827848.
    
          DOI: 10.1172/JCI174081.
      
 
                                          
                                                          
  Autoimmunity in Cardiomyopathy-Induced Heart Failure and Cardiac Autoantibody Removal by Immunoadsorption.
  
    Dandel M
    
    
    J Clin Med. 2025; 14(3).
  
  
    PMID: 39941618
    
          PMC: 11818089.
    
          DOI: 10.3390/jcm14030947.
      
 
                                          
                                                          
  Recent Trends in Achievement Rates and Time Required for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy.
  
    Wanezaki M, Watanabe T, Iizuka A, Kobayashi T, Edamura S, Sugai T
    
    
    Circ Rep. 2025; 7(2):97-105.
  
  
    PMID: 39931705
    
          PMC: 11807696.
    
          DOI: 10.1253/circrep.CR-24-0148.
      
 
                                          
                                                          
  Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.
  
    Wang Y, Hou Y, Hao T, Garcia-Contreras M, Li G, Cretoiu D
    
    
    Biomater Transl. 2025; 5(4):337-354.
  
  
    PMID: 39872935
    
          PMC: 11764187.
    
          DOI: 10.12336/biomatertransl.2024.04.002.
      
 
                                          
                                                          
  Left Ventricular Non-Compaction, Atrial Fibrillation and  Mutation in a Young Athlete.
  
    De Masi De Luca G, Brancati E, Sciarra L, Di Daniele A, Palama Z, Robles A
    
    
    J Clin Med Res. 2025; 17(1):60-65.
  
  
    PMID: 39866811
    
          PMC: 11753982.
    
          DOI: 10.14740/jocmr6126.
      
 
                                          
                                                          
  Left Ventricular Hypertrabeculation (LVHT) in Athletes: A Negligible Finding?.
  
    Jagminas R, Serpytis R, Serpytis P, Glaveckaite S
    
    
    Medicina (Kaunas). 2025; 61(1).
  
  
    PMID: 39859014
    
          PMC: 11767094.
    
          DOI: 10.3390/medicina61010032.
      
 
                                          
                                                          
  Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies.
  
    Jaimez-Alvarado S, Lopez-Tenorio I, Barragan-De Los Santos J, Bello-Vega D, Gomez F, Amedei A
    
    
    Biomedicines. 2025; 13(1).
  
  
    PMID: 39857728
    
          PMC: 11761909.
    
          DOI: 10.3390/biomedicines13010144.
      
 
                                          
                                                          
  Reversible Dilated Cardiomyopathy Associated With Herpes Simplex Virus Infection: A Case Report.
  
    Mendes T, Silva B, Sousa N
    
    
    Cureus. 2025; 16(12):e76174.
  
  
    PMID: 39840219
    
          PMC: 11750206.
    
          DOI: 10.7759/cureus.76174.
      
 
                                          
                                                          
  Etiology and Phenotypes of Cardiomyopathy in Southern Africa: The IMHOTEP Multicenter Pilot Study.
  
    Kraus S, Cirota J, Pandie S, Thomas K, Thomas M, Makotoko M
    
    
    JACC Adv. 2025; 3(12):100952.
  
  
    PMID: 39817068
    
          PMC: 11733814.
    
          DOI: 10.1016/j.jacadv.2024.100952.
      
 
                                          
                                                          
  Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology.
  
    Mlynarska E, Radzioch E, Dabek B, Leszto K, Witkowska A, Czarnik W
    
    
    Biomedicines. 2025; 12(12.
  
  
    PMID: 39767581
    
          PMC: 11727519.
    
          DOI: 10.3390/biomedicines12122675.
      
 
                                          
                                                          
  Hemodynamics in Left-Sided Cardiomyopathies.
  
    Monaco G, Amata F, Battaglia V, Panico C, Condorelli G, Pinto G
    
    
    Rev Cardiovasc Med. 2025; 25(12):455.
  
  
    PMID: 39742240
    
          PMC: 11683717.
    
          DOI: 10.31083/j.rcm2512455.